| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| H-M Guo, Z-Y Zhou, Y-Q Huang, X Li, X-J Wan. Investigation of the roles of dysbindin-1 and SATB2 in the progression of Parkinson's disease. European review for medical and pharmacological sciences. vol 23. issue 17. 2020-10-05. PMID:31539139. |
parkinson's disease is a neurodegenerative disease that typically results in the loss of dopaminergic neurons, especially in an area of the brain known as the substantia nigra. |
2020-10-05 |
2023-08-13 |
Not clear |
| Nishat Tasnim, Vikram Thakur, Munmun Chattopadhyay, Binata Jodda. The Efficacy of Graphene Foams for Culturing Mesenchymal Stem Cells and Their Differentiation into Dopaminergic Neurons. Stem cells international. vol 2018. 2020-10-02. PMID:29971110. |
the implantation of stem cells in vivo is the ideal approach for the restoration of normal life functions, such as replenishing the decreasing levels of affected dopaminergic (da) neurons during neurodegenerative disease conditions. |
2020-10-02 |
2023-08-13 |
mouse |
| Shane V Hegarty, Aideen M Sullivan, Gerard W O'Keeff. The Epigenome as a therapeutic target for Parkinson's disease. Neural regeneration research. vol 11. issue 11. 2020-10-01. PMID:28123403. |
parkinson's disease (pd) is a common, progressive neurodegenerative disease characterised by degeneration of nigrostriatal dopaminergic neurons, aggregation of α-synuclein and motor symptoms. |
2020-10-01 |
2023-08-13 |
Not clear |
| Laura Hühner, Jennifer Rilka, Ralf Gilsbach, Xiaolai Zhou, Venissa Machado, Björn Spitta. Interleukin-4 Protects Dopaminergic Neurons Frontiers in molecular neuroscience. vol 10. 2020-10-01. PMID:28337124. |
parkinson's disease (pd) is one the most common neurodegenerative disease and is characterized by the progressive loss of midbrain dopaminergic (mda) neurons in the substantia nigra resulting in bradykinesia, tremor, and rigidity. |
2020-10-01 |
2023-08-13 |
Not clear |
| Bahar Güntekin, Lütfü Hanoğlu, Dilan Güner, Nesrin H Yılmaz, Fadime Çadırcı, Nagihan Mantar, Tuba Aktürk, Derya D Emek-Savaş, Fahriye F Özer, Görsev Yener, Erol Başa. Cognitive Impairment in Parkinson's Disease Is Reflected with Gradual Decrease of EEG Delta Responses during Auditory Discrimination. Frontiers in psychology. vol 9. 2020-10-01. PMID:29515489. |
parkinson's disease (pd) is a neurodegenerative disease that is characterized by loss of dopaminergic neurons in the substantia nigra. |
2020-10-01 |
2023-08-13 |
human |
| Caroline W Spelt. Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management. Veterinary medicine (Auckland, N.Z.). vol 6. 2020-10-01. PMID:30101114. |
equine pituitary pars intermedia dysfunction (ppid) is a neurodegenerative disease of the hypothalamus, resulting in the loss of dopaminergic inhibition of pars intermedia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Junghyung Park, Jincheol Seo, Jinyoung Won, Hyeon-Gu Yeo, Yu-Jin Ahn, Keonwoo Kim, Yeung Bae Jin, Bon-Sang Koo, Kyung Seob Lim, Kang-Jin Jeong, Philyong Kang, Hwal-Yong Lee, Seung Ho Baek, Chang-Yeop Jeon, Jung-Joo Hong, Jae-Won Huh, Young-Hyun Kim, Sang-Je Park, Sun-Uk Kim, Dong-Seok Lee, Sang-Rae Lee, Youngjeon Le. Abnormal Mitochondria in a Non-human Primate Model of MPTP-induced Parkinson's Disease: Drp1 and CDK5/p25 Signaling. Experimental neurobiology. vol 28. issue 3. 2020-10-01. PMID:31308800. |
accumulating evidence suggests that mitochondrial dysfunction is related to neurodegenerative diseases such as parkinson's disease (pd), with excessive mitochondrial fission in dopaminergic neurons being one of the pathological mechanisms of pd. |
2020-10-01 |
2023-08-13 |
Not clear |
| Hendrik Schöneborn, Fabian Raudzus, Emilie Secret, Nils Otten, Aude Michel, Jérome Fresnais, Christine Ménager, Jean-Michel Siaugue, Holm Zaehres, Irmgard D Dietzel, Rolf Heuman. Novel Tools towards Magnetic Guidance of Neurite Growth: (I) Guidance of Magnetic Nanoparticles into Neurite Extensions of Induced Human Neurons and In Vitro Functionalization with RAS Regulating Proteins. Journal of functional biomaterials. vol 10. issue 3. 2020-10-01. PMID:31315182. |
parkinson's disease (pd) is a neurodegenerative disease associated with loss or dysfunction of dopaminergic neurons located in the substantia nigra (sn), and there is no cure available. |
2020-10-01 |
2023-08-13 |
human |
| Nicoletta L Lilli, Delphine Révy, Sandra Robelet, Béatrice Lejeun. Effect of the micro-immunotherapy medicine 2LPARK Degenerative neurological and neuromuscular disease. vol 9. 2020-10-01. PMID:31372089. |
effect of the micro-immunotherapy medicine 2lpark parkinson's disease (pd) is a neurodegenerative disease characterized by motor impairments and resulting from progressive degenerative loss of midbrain dopaminergic (daergic) neurons in the substantia nigra. |
2020-10-01 |
2023-08-13 |
Not clear |
| Koji Ohir. Dopamine as a growth differentiation factor in the mammalian brain. Neural regeneration research. vol 15. issue 3. 2020-10-01. PMID:31571646. |
in this mini-review, i center my attention on dopaminergic functions in the cortical interneurons during development and further discuss cell therapy against neurodegenerative diseases. |
2020-10-01 |
2023-08-13 |
Not clear |
| Shulei Lei, Robert Power. NMR Metabolomics Analysis of Parkinson's Disease. Current Metabolomics. vol 1. issue 3. 2020-09-30. PMID:26078917. |
parkinson's disease (pd) is a neurodegenerative disease, which is characterized by progressive death of dopaminergic neurons in the substantia nigra pars compacta. |
2020-09-30 |
2023-08-13 |
Not clear |
| Guo-Qing Wang, Dai-Di Li, Chun Huang, Di-Sheng Lu, Chao Zhang, Shao-Yu Zhou, Jie Liu, Feng Zhan. Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation Frontiers in molecular neuroscience. vol 10. 2020-09-30. PMID:29375304. |
icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation parkinson's disease (pd) is one of the most common neurodegenerative diseases characterized with a gradual loss of midbrain substantia nigra (sn) dopamine (da) neurons. |
2020-09-30 |
2023-08-13 |
rat |
| Xian-Si Zeng, Wen-Shuo Geng, Jin-Jing Jia, Lei Chen, Peng-Peng Zhan. Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease. Frontiers in aging neuroscience. vol 10. 2020-09-30. PMID:29719505. |
the disease is the second most common neurodegenerative disease characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. |
2020-09-30 |
2023-08-13 |
Not clear |
| Pavel V Nekrasov, Vasily V Vorobyo. Dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells. Neural regeneration research. vol 13. issue 4. 2020-09-30. PMID:29722315. |
dopaminergic mediation in the brain aging and neurodegenerative diseases: a role of senescent cells. |
2020-09-30 |
2023-08-13 |
Not clear |
| Bing Wang, Cun-Jin Su, Teng-Teng Liu, Yan Zhou, Yu Feng, Ya Huang, Xu Liu, Zhi-Hong Wang, Li-Hua Chen, Wei-Feng Luo, Tong Li. The Neuroprotection of Low-Dose Morphine in Cellular and Animal Models of Parkinson's Disease Through Ameliorating Endoplasmic Reticulum (ER) Stress and Activating Autophagy. Frontiers in molecular neuroscience. vol 11. 2020-09-30. PMID:29731707. |
parkinson's disease (pd) is a common neurodegenerative disease characterized the progressive loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snc). |
2020-09-30 |
2023-08-13 |
Not clear |
| Na Feng, Scott Simanski, Kazi Islam, Linda S Hynan, Thomas Kodadek, Dwight C Germa. Antibody biomarker for de novo Parkinson disease: attempted validation. NPJ Parkinson's disease. vol 4. 2020-09-30. PMID:30211310. |
parkinson disease (pd) is a progressive neurodegenerative disease with motor symptoms that result from degeneration of midbrain dopaminergic neurons. |
2020-09-30 |
2023-08-13 |
human |
| Yousheng Mo, Erjin Xu, Renrong Wei, Baoluu Le, Lei Song, Dongli Li, Yonggen Chen, Xiaotian Ji, Shuhuan Fang, Jiangang Shen, Cong Yang, Qi Wan. Bushen-Yizhi Formula Alleviates Neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson's Disease. Evidence-based complementary and alternative medicine : eCAM. vol 2018. 2020-09-30. PMID:30224927. |
parkinson's disease (pd), the second most common neurodegenerative disease, is characterized by the progressive loss of dopaminergic neurons in the substantia nigra. |
2020-09-30 |
2023-08-13 |
mouse |
| Hong-Hua Qiao, Lin-Nan Zhu, Yue Wang, Jia-Liang Hui, Wei-Bing Xie, Chao Liu, Ling Chen, Ping-Ming Qi. Implications of alpha-synuclein nitration at tyrosine 39 in methamphetamine-induced neurotoxicity Neural regeneration research. vol 14. issue 2. 2020-09-30. PMID:30531016. |
implications of alpha-synuclein nitration at tyrosine 39 in methamphetamine-induced neurotoxicity methamphetamine is an amphetamine-type psychostimulant that can damage dopaminergic neurons and cause characteristic pathological changes similar to neurodegenerative diseases such as parkinson's disease. |
2020-09-30 |
2023-08-13 |
mouse |
| Elisa Storelli, Niccolò Cassina, Emanuela Rasini, Franca Marino, Marco Cosentin. Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence. Frontiers in neurology. vol 10. 2020-09-30. PMID:30733703. |
parkinson's disease (pd) is a neurodegenerative disease characterized by progressive loss of dopaminergic neurons, appearance of lewy bodies and presence of neuroinflammation. |
2020-09-30 |
2023-08-13 |
Not clear |
| Jin-Sun Park, Yea-Hyun Leem, Jung-Eun Park, Do-Yeon Kim, Hee-Sun Ki. Neuroprotective Effect of β-Lapachone in MPTP-Induced Parkinson's Disease Mouse Model: Involvement of Astroglial p-AMPK/Nrf2/HO-1 Signaling Pathways. Biomolecules & therapeutics. vol 27. issue 2. 2020-09-30. PMID:30739428. |
parkinson's disease is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons within the substantia nigra pars compacta. |
2020-09-30 |
2023-08-13 |
mouse |